JAKUB TOLAR to Survival Analysis
This is a "connection" page, showing publications JAKUB TOLAR has written about Survival Analysis.
Connection Strength
0.178
-
Hematopoietic cell therapy for metabolic disease. J Pediatr. 2007 Oct; 151(4):340-6.
Score: 0.052
-
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita. Br J Haematol. 2018 10; 183(1):110-118.
Score: 0.027
-
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. Biol Blood Marrow Transplant. 2017 Sep; 23(9):1422-1428.
Score: 0.025
-
Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres. Mol Genet Metab. 2016 Mar; 117(3):373-7.
Score: 0.023
-
An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes. Biol Blood Marrow Transplant. 2015 Jan; 21(1):81-8.
Score: 0.021
-
Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011 Aug 18; 118(7):1971-8.
Score: 0.017
-
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood. 2007 Nov 01; 110(9):3480-8.
Score: 0.013